Argent Biopharma Limited has released a press release.
Company Update & Capital Raising
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Retraction of Statement
- Pause in trading
- Share Purchase Plan Closed
- Pre-clinical Trial Results on CimetrA
- MGC Pharma Launches Share Purchase Plan
Later from Argent Biopharma
- Placing to Raise US$500,000
- Placing to Raise US$2,000,000
- Voluntary Delisting from ASX
- Preliminary Final Report
- Placing to Raise A$200,000
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma